Subscribe Us

header ads

Recents

header ads

Probiotic Ingredients Market Size At Around US$ 14,269 Mn In 2030

The probiotic ingredients market would grow at a CAGR of 12.42% over the predicted time frame. The market is expected to increase in value from US$ 5,591.41 Mn in 2022 to US$ 14,269  Mn in 2030.

Probiotic Ingredients Market Size 2021 to 2030

The on probiotic ingredients Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1826

Report Scope of the Probiotic Ingredients Market

Report CoverageDetails
Market Size by 2030USD 14,269 Million
Growth Rate from 2022 to 2030

CAGR of 12.42%

Europe Market Share in 202138%
Fastest Growing RegionAsia Pacific
Base Year2021
Forecast Period2022 to 2030
Segments CoveredProbioFerm, Glac Biotech, DSM, Vitakem Nutraceutical, Inc., Bio Gaia, Probium, Kerry Group

A recent report provides crucial insights along with application based and forecast information in the Global Probiotic ingredients Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Probiotic ingredients market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Probiotic ingredients market are included as given below:

Probiotic ingredients Market Key Players    

  • ProbioFerm
  • Glac Biotech
  • DSM
  • Vitakem Nutraceutical, Inc.
  • Bio Gaia
  • Probium
  • Kerry Group

Market Segments

 By Type 

  • Bifidobacterium animalis
  • Bifidobacterium breve
  • Bifidobacterium longum
  • Lactobacillus Reuteri

By Application

  • Food and Beverages
    • Dairy Products
      • Yogurt
      • Cheese
      • Other
    • Non-dairy Products
      • Vegetable-based probiotic products
      • Fruit-based probiotic products
      • Meat-based probiotic products
  • Dietary Supplements
    • Tablets
    • Probiotic Drinks
    • Powders
    • Capsules
    • Powder
    • Granule 
  • Animal Feed

By Components

  • Bacterica
  • Yeast

By Form 

  • Dry Form
  • Liquid Form

By End User

  • Human Probiotic
  • Animal Probiotic

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Report Objectives

  • To define, describe, and forecast the global probiotic ingredients market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the probiotic ingredients market

Table of Content

 Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Probiotic Ingredients Market 

5.1. COVID-19 Landscape: Probiotic Ingredients Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Probiotic Ingredients Market, By Type

8.1. Probiotic Ingredients Market, by Type, 2022-2030

8.1.1. Bifidobacterium animalis

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Bifidobacterium breve

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Bifidobacterium longum

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Lactobacillus Reuteri

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Probiotic Ingredients Market, By Application

9.1. Probiotic Ingredients Market, by Application, 2022-2030

9.1.1. Food and Beverages

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Dietary Supplements

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Animal Feed

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Probiotic Ingredients Market, By Components 

10.1. Probiotic Ingredients Market, by Components, 2022-2030

10.1.1. Bacterica

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Yeast

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Probiotic Ingredients Market, By Form

11.1. Probiotic Ingredients Market, by Form, 2022-2030

11.1.1. Dry Form

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Liquid Form

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Probiotic Ingredients Market, By End User

12.1. Probiotic Ingredients Market, by End User, 2022-2030

12.1.1. Human Probiotic

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Animal Probiotic

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Probiotic Ingredients Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.3. Market Revenue and Forecast, by Components (2017-2030)

13.1.4. Market Revenue and Forecast, by Form (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Components (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Form (2017-2030)

13.1.7. Market Revenue and Forecast, by End User (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Components (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Form (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.3. Market Revenue and Forecast, by Components (2017-2030)

13.2.4. Market Revenue and Forecast, by Form (2017-2030) 

13.2.5. Market Revenue and Forecast, by End User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Components (2017-2030)

13.2.7. Market Revenue and Forecast, by Form (2017-2030) 

13.2.8. Market Revenue and Forecast, by End User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Components (2017-2030)

13.2.10. Market Revenue and Forecast, by Form (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Components (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Form (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Components (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Form (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.3. Market Revenue and Forecast, by Components (2017-2030)

13.3.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Components (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Components (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Components (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Components (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.3. Market Revenue and Forecast, by Components (2017-2030)

13.4.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Components (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Components (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Components (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Components (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.3. Market Revenue and Forecast, by Components (2017-2030)

13.5.4. Market Revenue and Forecast, by Form (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Components (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Form (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Components (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Form (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. ProbioFerm

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Glac Biotech

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. DSM

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Vitakem Nutraceutical, Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Bio Gaia

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Probium

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Kerry Group

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments